The Health Products Regulation Group ensures that drugs, innovative therapeutics, medical devices and health-related products in Singapore are wisely regulated to meet appropriate standards of safety, quality and efficacy. The Group comprises:

• Therapeutic Products Division
• Complementary Health Products Division
• Manufacturing & Quality Audit Division
• Pharmacovigilance & Compliance Division
• Enforcement Division

For more information on the organisation structure of HPRG, please click here.

• Medicines

  The Medicines Act requires all medicinal products sold in Singapore and manufactured locally for export to be licensed with the Health Products Regulation Group, Health Sciences Authority.

• Complementary Medicines

  The Complementary Medicines Branch oversees the regulation of Chinese Proprietary Medicines, other Traditional Medicines and Health Supplements.

• Cosmetic Products

  The Cosmetics Control Unit (CCU) was set up in November 1995 to administer the regulatory control of cosmetic products.

• Medical Devices

  Medical devices are critical to the delivery of healthcare and cover a wide range of health or medical instruments used in the treatment, mitigation, diagnosis or prevention of disease or abnormal physical condition.

• Control of Tobacco

  The Tobacco Regulation Unit was set up in 1989 to administer and enforce the Smoking (Control of Advertisements & Sale of Tobacco) Act (Chapter 309), with the objective of reducing the prevalence of smoking among Singaporeans. The act provides for the control on the following: Prohibition of smoking by youths below the age of 18; Prohibition on the sale and supply of tobacco products to youths below the age of 18; Prohibition of smoking-related advertisements and promotion of tobacco products; Mandatory labelling of health warnings on tobacco products; Tar and nicotine content limits in cigarettes; and Licensing of tobacco importers/wholesalers and retailers.

• Clinical Trials

  All clinical trials on medicinal products conducted in Singapore requires Clinical Trial Certificates (CTC) from the Centre for Drug Administration, Health Sciences Authority. The Medical Clinical Research Committee (MCRC) provides advice on the licensing of clinical drug trials.

• Manufacturing, Importation & Distribution

  The Good Manufacturing Practice Unit was formed in April 1997 within the National Pharmaceutical Administration (NPA) of the Ministry of Health to centralise the inspection of manufacturers of medicinal and cosmetic products under one specialised unit.

• Medical Advertisements and Sales Promotion

  The objective of advertisement control of medicinal products is to ensure that medicinal products advertised or promoted for sale to the general public do not affect public health, mislead or induce unnecessary use.

• Safety Information and Recalls

  Information on safety issues and product recalls related to medicinal products, complementary medicines and cosmetics for healthcare professionals and members of the public.

• Consumer Advice

  Important information for consumers on health products and medical devices.

• Bringing Personal Medication into Singapore

  This guidance document issued by the Health Products Regulation Group, Health Sciences Authority, provides visitors to Singapore with the current regulatory requirements for medicines brought into Singapore for personal use.